4 completed, 1 not yet recruiting. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow Inhalational Anthrax: new trials by email Literature Review of Inhalational Anthrax trials Research Report on Inhalational Anthrax
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients AIGIV - Inhalational Anthrax | Not yet recruiting | Emergent BioSolutions | 100 | 2027-05-30 | 2026-02-06 | |
| Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers ETI-204, Ciprofloxacin - Inhalational Anthrax | Phase 1 | Completed | Elusys Therapeutics | 40 | 2013-10-29 | 2019-04-16 |
| Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers ETI-204, Placebo - Inhalational Anthrax | Phase 1 | Completed | Elusys Therapeutics | 36 | 2013-07-26 | 2019-05-06 |
| Safety, Tolerability and PK of Repeat Administration of Intravenous ETI-204 in Adult Volunteers ETI-204, Placebo - Inhalational Anthrax | Phase 1 | Completed | Elusys Therapeutics | 70 | 2013-07-23 | 2019-05-14 |
| Safety, Tolerability, and PK of a Single Intravenous Dose of ETI-204 in Adult Volunteers ETI-204, Placebo - Inhalational Anthrax | Phase 1 | Completed | Elusys Therapeutics | 280 | 2013-07-09 | 2019-04-08 |
Inhalation anthrax (5) · Anthrax (3) · Bacterial Infections (1)
Bacillaceae Infections (3) · Bacterial Infections and Mycoses (3) · Gram-Positive Bacterial Infections (3) · Infections (3) · Bacterial Infections (2)
obiltoxaximab (4) · Anthrax Immune Globulin Intravenous (1) · Ciprofloxacin (1)
Elusys Therapeutics (4) · Emergent BioSolutions (1)
United States (4)
Alex King, MD (2) · David Mathews, MD (2) · Brandon Essink, MD (1) · Debra Mandarino, MD (1) · H. Frank Farmer, PhD, MD (1) · Jolene Berg, MD (1) · Lori Sieboldt, MD (1)